TABLE 2.
Antibiotic | MIC (μg/ml) for:
|
||||||
---|---|---|---|---|---|---|---|
Nalidixic acid-susceptible isolates (n = 62)
|
Nalidixic acid-resistant isolates (n = 124)
|
Ciprofloxacin-resistant isolatesa (n = 5) | |||||
50% | 90% | Range | 50% | 90% | Range | ||
Nalidixic acid | 4 | 8 | 4-8 | 512 | >1,024 | 128->1,024 | >1,024 |
Norfloxacin | 0.12 | 0.12 | 0.12 | 1 | 2 | 0.25-4 | >16 |
Enrofloxacin | 0.06 | 0.06 | 0.06 | 0.5 | 1 | 0.25-2 | >32b |
Ciprofloxacin | 0.03 | 0.06 | 0.03-0.06 | 0.25 | 0.5 | 0.25-2.0 | 16 |
The five isolates were Salmonella serovar Typhimurium DT104.
Determined by Etest.